| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion due to NICE appraisal TA124: Pemetrexed for the treatment of non-small-cell lung cancer |
|
Medicine details |
|
| Medicine name | pemetrexed (Alimta®) |
| Formulation | powder for concentrate for solution for infusion |
| Reference number | 246 |
| Indication | Monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after prior chemotherapy |
| Company | Eli Lilly & Co Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 22/08/2007 |
| NICE guidance | TA124: Pemetrexed for the treatment of non-small-cell lung cancer |